Topic: MS

Three biomarkers of DMT adverse effects proposed

August 25, 2022  

Is a cell-depleting DMT safe prior to HSCT?

August 9, 2022  

COVID-19 and MS – updated findings

July 28, 2022  

Key changes in Canadian MS care during the pandemic

July 7, 2022  

Pandemic prescribing – what changed?

July 6, 2022  

How much B cell suppression is needed in MS?

May 30, 2022  

Revisions proposed for McDonald criteria

May 27, 2022  

Evolving picture of cognitive dysfunction in MS

May 19, 2022  

6 criteria to improve PMS outcomes

May 2, 2022  

AAN report: long-term data for anti-CD20s, BTK inhibitors

April 25, 2022